Functional impact bias reveals cancer drivers

Nucleic Acids Research

Volumn 40, Issue 21, 2012, Pages

  Gonzalez Perez, Abel ^a   Lopez Bigas, Nuria ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SELECTION; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; ONCODRIVE FM; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC ERROR;

GENES, NEOPLASM; GENETIC VARIATION; GENOMICS; HUMANS; MUTATION;

EID: 84870599966     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks743     Document Type: Article

References (47)

1. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
2. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183. (Pubitemid 38337497)
3. Wood, L.D., Parsons, D.W., Jones, S., Lin, J., Sjöblom, T., Leary, R.J., Shen, D., Boca, S.M., Barber, T., Ptak, J. et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science, 318, 1108-1113. (Pubitemid 350134889)
4. Agrawal, N., Frederick, M.J., Pickering, C.R., Bettegowda, C., Chang, K., Li, R.J., Fakhry, C., Xie, T.-X., Zhang, J., Wang, J. et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science, 333, 1154-1157.
5. ICGC. (2010) International network of cancer genome projects. Nature, 464, 993-998.
6. The Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
7. Cancer Genome Atlas Research Network. (2011) Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609-615.
8. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158. (Pubitemid 46398669)
9. Parmigiani, G., Boca, S., Lin, J., Kinzler, K.W., Velculescu, V. and Vogelstein, B. (2009) Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics, 93, 17-21.
10. Getz, G., Höfling, H., Mesirov, J.P., Golub, T.R., Meyerson, M., Tibshirani, R. and Lander, E.S. (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science, 317, 1500.
11. Lin, J., Gan, C.M., Zhang, X., Jones, S., Sjöblom, T., Wood, L.D., Parsons, D.W., Papadopoulos, N., Kinzler, K.W., Vogelstein, B. et al. (2007) A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res., 17, 1304-1318. (Pubitemid 47360905)
12. Ding, L., Getz, G., Wheeler, D.A., Mardis, E.R., McLellan, M.D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D.M., Morgan, M.B. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
13. Kan, Z., Jaiswal, B.S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H.M., Yue, P., Haverty, P.M., Bourgon, R., Zheng, J. et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature, 466, 869-873.
14. Shah, S.P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G. et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486, 395-399.
15. Ng, P.C. and Henikoff, S. (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812-3814. (Pubitemid 37442253)
16. Kumar, P., Henikoff, S. and Ng, P.C. (2009) Predicting the effects of coding non-synonymous variants on protein function using the {SIFT} algorithm. Nat. Protoc., 4, 1073-1081.
17. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
18. Reva, B., Antipin, Y. and Sander, C. (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res., 1-14.
19. Carter, H., Chen, S., Isik, L., Tyekucheva, S., Velculescu, V.E., Kinzler, K.W., Vogelstein, B. and Karchin, R. (2009) Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res., 69, 6660-6667.
20. Gundem, G., Perez-Llamas, C., Jene-Sanz, A., Kedzierska, A., Islam, A., Deu-Pons, J., Furney, S.J. and Lopez-Bigas, N. (2010) IntOGen: integration and data mining of multidimensional oncogenomic data. Nat. Methods, 7, 92-93.
21. Ciriello, G., Cerami, E.G., Sander, C. and Schultz, N. (2011) Mutual exclusivity analysis identifies oncogenic network modules. Genome Res., 22, 398-406.
22. Fujita, P.A., Rhead, B., Zweig, A.S., Hinrichs, A.S., Karolchik, D., Cline, M.S., Goldman, M., Barber, G.P., Clawson, H., Coelho, A. et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res., 39, D876-D882.
23. McLaren, W., Pritchard, B., Rios, D., Chen, Y., Flicek, P. and Cunningham, F. (2010) Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics, 26, 2069-2070.
24. Quesada, V., Conde, L., Villamor, N., Ordóñ ez, G.R., Jares, P., Bassaganyas, L., Ramsay, A.J., Beà , S., Pinyol, M., Mart?́nez-Trillos, A. et al. (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet., 44, 47-52.
25. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C.-H., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G.L. et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-1812.
26. Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B. et al. (2011) International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data. Database, 2011, bar026.
27. The 1000 Genomes Project Consortium. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
28. Whitlock, M.C. (2005) Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J. Evol. Biol., 18, 1368-1373. (Pubitemid 41725687)
29. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550. (Pubitemid 41528093)
30. Marcato, P., Dean, C.A., Giacomantonio, C.A. and Lee, P.W.K. (2011) Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle, 10, 1378-1384.
31. Muzio, G., Maggiora, M., Paiuzzi, E., Oraldi, M. and Canuto, R.A. (2012) Aldehyde dehydrogenases and cell proliferation. Free Radical Bio. Med., 52, 735-746.
32. Acevedo, V.D., Ittmann, M. and Spencer, D.M. (2009) Paths of FGFR-driven tumorigenesis. Cell Cycle, 8, 580-588.
33. Schwertfeger, K.L. (2009) Fibroblast growth factors in development and cancer: insights from the mammary and prostate glands. Curr. Drug Targets, 10, 632-644.
34. Haugsten, E.M., Wiedlocha, A., Olsnes, S. and Wesche, J. (2010) Roles of fibroblast growth factor receptors in carcinogenesis. Mol. Cancer Res., 8, 1439-1452.
35. Turjanski, A.G., Vaqué , J.P. and Gutkind, J.S. (2007) MAP kinases and the control of nuclear events. Oncogene, 26, 3240-3253. (Pubitemid 46763018)
36. Saadeddin, A., Babaei-Jadidi, R., Spencer-dene, B. and Nateri, A.S. (2009) The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol. Cancer Res., 7, 1189-1196.
37. Cerami, E., Demir, E., Schultz, N., Taylor, B.S. and Sander, C. (2010) Automated network analysis identifies core pathways in glioblastoma. PLoS ONE, 5, e8918.
38. Liu, Y., Shete, S., Hosking, F.J., Robertson, L.B., Bondy, M.L. and Houlston, R.S. (2010) New insights into susceptibility to glioma. Arch. Neurol., 67, 275-278.
39. Nagarajan, P., Onami, T.M., Rajagopalan, S., Kania, S., Donnell, R. and Venkatachalam, S. (2009) Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene, 28, 1053-1062.
40. Golomb, L., Bublik, D.R., Wilder, S., Nevo, R., Kiss, V., Grabusic, K., Volarevic, S. and Oren, M. (2012) Importin 7 and Exportin 1 Link c-Myc and p53 to regulation of ribosomal biogenesis. Mol. cell, 45, 222-232.
41. Li, S.R., Gyselman, V.G., Dorudi, S. and Bustin, S.A. (2000) Elevated levels of RanBP7 mRNA in colorectal carcinoma are associated with increased proliferation and are similar to the transcription pattern of the proto-oncogene c-myc. Biochem. Biophys. Res. Commun., 271, 537-543. (Pubitemid 30444760)
42. Balatti, V., Bottoni, A., Palamarchuk, A., Alder, H., Rassenti, L.Z., Kipps, T.J., Pekarsky, Y. and Croce, C.M. (2011) NOTCH1 mutations in CLL associated with trisomy 12. Blood, 119, 329-331.
43. Wang, L., Lawrence, M.S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D.S., Zhang, L. et al. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New Engl. J. Med., 365, 111212103035002.
44. Siddiqui, N. and Borden, K.L.B. mRNA export and cancer. Wiley interdisciplinary reviews. RNA, 3, 13-25.
45. Hahn, C.N. and Scott, H.S. (2011) Spliceosome mutations in hematopoietic malignancies. Nat. Genet., 44, 9-10.
46. Graubert, T.A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C.L., Shao, J., Krysiak, K., Harris, C.C., Koboldt, D.C., Larson, D.E. et al. (2011) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet., 44, 53-57.
47. Perez-Llamas, C. and Lopez-Bigas, N. (2011) Gitools: analysis and visualisation of genomic data using interactive heat-maps. PLoS ONE, 6, e19541.